KLK(Lanadelumab Biosimilar)是一種重組單克隆抗體，主要用于科研領(lǐng)域的相關(guān)研究工作。作為一款重組單克隆抗體產(chǎn)品，它具有高度的特異性和靶向性，能夠與特定的抗原進(jìn)行精準(zhǔn)結(jié)合，為科研人員在生物醫(yī)學(xué)研究中提供有力的工具支持。 在科研應(yīng)用中，KLK可用于多種實(shí)驗(yàn)場(chǎng)景。例如，在蛋白質(zhì)相互作用研究中，它可以特異性識(shí)別目標(biāo)蛋白，幫助研究人員探究蛋白質(zhì)之間的結(jié)合機(jī)制和功能關(guān)系；在細(xì)胞生物學(xué)研究中，能夠通過(guò)與細(xì)胞表面特定受體結(jié)合，深入了解細(xì)胞信號(hào)傳導(dǎo)通路的調(diào)控過(guò)程。 該重組單克隆抗體的研發(fā)和生產(chǎn)遵循嚴(yán)格的質(zhì)量控制標(biāo)準(zhǔn)，確保產(chǎn)品的純度、活性和穩(wěn)定性，以滿足科研實(shí)驗(yàn)對(duì)結(jié)果準(zhǔn)確性和可重復(fù)性的要求。科研人員可以利用KLK開(kāi)展相關(guān)的基礎(chǔ)研究、疾病機(jī)制探索等工作，為生命科學(xué)領(lǐng)域的發(fā)展提供有價(jià)值的實(shí)驗(yàn)數(shù)據(jù)和研究思路。 通過(guò)對(duì)KLK的應(yīng)用，科研人員能夠更深入地探索生物體內(nèi)的分子機(jī)制，為進(jìn)一步的醫(yī)學(xué)研究和藥物開(kāi)發(fā)等領(lǐng)域奠定堅(jiān)實(shí)的科研基礎(chǔ)，推動(dòng)相關(guān)學(xué)科的不斷發(fā)展與進(jìn)步。

#N A

KLK

Anti-plasma kallikrein mAb research-grade biosimilar; Anti-plasma kallikrein monoclonal antibody research-grade biosimilar; DX-2930 research-grade biosimilar; lanadelumab research-grade biosimilar; Lanadelumab (genetical recombination) research-grade biosimilar; Lanadelumab (genetical recombination) (JAN) research-grade biosimilar; Lanadelumab (USAN) research-grade biosimilar; Lanadelumab-flyo research-grade biosimilar; LANDELUMAB-FLYO research-grade biosimilar; SHP 643 research-grade biosimilar; SHP-643 research-grade biosimilar; TAK-743 research-grade biosimilar; Takhzyro research-grade biosimilar; X124-G01 research-grade biosimilar; ????? research-grade biosimilar

Human

Recombinant Human KLK protein

Homo sapiens (Human)

Non-conjugated

Monoclonal

It differs from different batches. Please contact us to confirm it.

0.01M PBS,pH7.4

Liquid

Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity?> 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

3-4 weeks

It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.